FDA
-
-
-
-
-
-
-
MeiraGTx Holdings plc (MGTX) PT Raised to $30 at Piper Sandler 'Remain Buyers'
-
-
-
-
-
-
-
MeiraGTx Holdings plc (MGTX) PT Lowered at Piper Sandler; 'We see meaningful upside to the stock'
-
-
-
-
-
-
-
MeiraGTx partners with Eli Lilly on eye disease gene therapies
-
-
-
-
-
-
-
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson’s Disease
-
-
-
-
-
-
-
MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D Mutations
-
-
-
-
-
-
-
MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease
-
-
-
-
-
-
-
MeiraGTx Holdings (MGTX) Announces $50 Million Milestone from Janssen Pharmaceuticals
-
334,273 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


